Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 5:38 PM ET

Pharmaceuticals

Company Overview of Merck Serono S.A.

Company Overview

Merck Serono S.A., a biopharmaceutical company, discovers, develops, manufactures, and commercializes prescription medicines of chemical and biological origin in specialist indications. It develops drugs for neurodegenerative diseases, such as Rebif, a disease modifying drug to treat relapsing forms of multiple sclerosis; and Erbitux, an IgG1 monoclonal antibody targeting the epidermal growth factor receptor for treating squamous cell carcinoma of the head and neck, and metastatic colorectal cancer. The company also develops fertility drugs for various stages of the reproductive cycle and recombinant versions of various hormones to treat infertility, such as GONAL-f, a recombinant human foll...

Frankfurter Strasse 250

Darmstadt,  64293

Germany

Founded in 1987

4,775 Employees

Phone:

49 6151 72 0

Fax:

49 6151 72 2000

Key Executives for Merck Serono S.A.

Chief Executive Officer and President
Age: 55
Head of Global Business Unit Allergy and Chief Executive Officer of Allergopharma
Age: 44
Chief Executive Officer of Consumer Health and President of Consumer Health
Head of Legal and Senior Vice President
Age: 77
Head of Global Business Development and Executive Vice President of Global Business Development & Strategy
Compensation as of Fiscal Year 2015.

Merck Serono S.A. Key Developments

Merck Serono S.A. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 12:00 PM

Merck Serono S.A. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 12:00 PM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States. Speakers: Philippe Lopes-Fernandes, Senior VP, Head, Global Licensing and Business Development.

Merck Serono S.A. Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2015 10:00 AM

Merck Serono S.A. Presents at 15th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2015 10:00 AM. Venue: Congress Center, Basel, Switzerland.

Merck Serono S.A. Presents at ChinaBio Leadership Retreat 2015, Oct-22-2015

Merck Serono S.A. Presents at ChinaBio Leadership Retreat 2015, Oct-22-2015 . Venue: Changshu, China.

Similar Private Companies By Industry

Company Name Region
Teva GmbH Europe
Alopex GmbH Europe
Merz Pharma GmbH & Co. KGaA Europe
SanguiBioTech GmbH Europe
Pfizer Manufacturing Deutschland GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Merck Serono S.A., please visit www.merckserono.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.